Clearstead Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103 Buy
+1
New +$59 ﹤0.01% 3349
2025
Q4
Sell
-103
Closed -$2.21K 2780
2025
Q3
$2.21K Buy
+103
New +$2.31K ﹤0.01% 2419

Other funds holding ATEX

Clearstead Advisors's ATEX Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Anterix (ATEX) in Q2 2026: 1 share worth $103. The stake represents ﹤0.01% of the portfolio and ranks #3349 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ATEX as recently as Q3 2025.

Clearstead Advisors first reported a position in ATEX in Q3 2025 and has held it in 2 quarters since. The position peaked at $2.21K in Q3 2025. 59 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Clearstead Advisors held 1 share of Anterix worth $103 as of Q2 2026.
  • Anterix was a new Clearstead Advisors position in Q2 2026.
  • Anterix made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3349 holding.
  • Clearstead Advisors first reported a position in Anterix in Q3 2025 and has held it in 2 quarters since.
  • Clearstead Advisors's Anterix position peaked at $2.21K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.